DF/HCC Tumor Imaging Metrics Core 20th Anniversary
Published 3/4/2025
The 20th anniversary of the DF/HCC Tumor Imaging Metrics Core (TIMC) was a momentous occasion, celebrated on November 2, 2024, at the Craft Food Hall in Waltham, MA. This milestone marked two decades of dedication to advancing oncologic clinical trials through high-quality tumor imaging metrics. Since its inception in 2004, TIMC has been a cornerstone in the evaluation of novel cancer therapies, providing essential support to clinical research investigators and patients. The anniversary was a testament to the Core's unwavering commitment to improving the quality and efficiency of tumor imaging assessments, which have been pivotal in trial eligibility and treatment decisions.
Over the years, TIMC has evolved into a multi-institutional, multidisciplinary service, processing over 12,000 scans annually and supporting more than 2,100 active clinical trials across 13 institutions. Its innovative informatics platform, developed and licensed to Yunu, Inc., has set a new standard for managing workflow, compliance, and imaging assessments. This platform has not only enhanced TIMC's capabilities but also facilitated collaboration with other cancer centers, creating a trans-cancer center clinical trials imaging research community. The Core's efforts have extended beyond DF/HCC, sharing expertise and tools with 12 NCI-designated Cancer Centers across the U.S.
As TIMC celebrated this significant anniversary, the focus was not only on past achievements but also on the future. The Core's team, including directors, image analysts, radiologists, and support staff, remains committed to staying at the forefront of clinical research trends and needs. By continuously engaging in new assessment criteria and contributing to scientific literature, TIMC is poised to further its impact on cancer research and treatment. The anniversary was a reminder of the Core's vital role in bringing effective treatments to patients and its ongoing mission to support clinical trials with accurate, timely imaging assessments.